Longevity experts have discovered why so many people in Brazil live past the age of 110, making them super-centenarians.
RVMD stays a Strong Buy as RAS inhibitor trials advance; phase 3 RASolute-302 is a key 2026 catalyst. Read the latest ...
The predicted surge of influenza cases, driven by the new “subclade K” mutation, is hitting Rhode Island emergency rooms as ...
Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback